LOW FEASIBILITY OF SECOND-LINE CHEMOTHERAPY IN PATIENTS WITH DIABETES MELLITUS IN ADVANCED NON-SMALL CELL LUNG CANCER

被引：0
|
作者：
Kogure, Yoshihito [1 ]
Hori, Kazumi [1 ]
Funahashi, Yoriko [1 ]
Oka, Saori [1 ]
Tsuboi, Rie [1 ]
Adachi, Takashi [1 ]
Ryuge, Misaki [1 ]
Murata, Naohiko [1 ]
Kitagawa, Chiyoe [1 ]
Oki, Masahide [1 ]
Saka, Hideo [1 ]
机构：
[1] Nagoya Med Ctr, Nagoya, Aichi, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2011年 / 6卷 / 06期
关键词：
NSCLC; Chemotherapy; diabetes mellitus;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S1182 / S1183
页数：2
相关论文
共 50 条
  • [1] FREQUENCY OF SECOND-LINE CHEMOTHERAPY FOR ELDERLY PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER
    Suzuki, Kensuke
    Kenmotsu, Hirotsugu
    Taira, Tetsuhiko
    Naito, Tateaki
    Kimura, Madoka
    Hisamatsu, Yasushi
    Tokito, Takaaki
    Imai, Hisao
    Akamatsu, Hiroaki
    Ono, Akira
    Shukuya, Takehito
    Murakami, Haruyasu
    Takahashi, Toshiaki
    Endo, Masahiro
    Yamamoto, Nobuyuki
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (11) : S484 - S484
  • [2] Gemcitabine in the first and second-line chemotherapy of advanced non-small cell lung cancer
    Cucevic, B
    Samarzija, M
    Baricevic, D
    Jakopovic, M
    Redzepi, G
    Samija, M
    COLLEGIUM ANTROPOLOGICUM, 2005, 29 (02) : 583 - 588
  • [3] Second-line chemotherapy for non-small cell lung cancer
    De Marinis, F.
    De Santis, S.
    De Petris, L.
    ANNALS OF ONCOLOGY, 2006, 17 : V68 - V71
  • [4] Second-Line Chemotherapy and Beyond for Non-Small Cell Lung Cancer
    Durm, Greg
    Hanna, Nasser
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2017, 31 (01) : 71 - +
  • [5] Efficacy of second-line chemotherapy after immunotherapy in advanced non-small cell lung cancer
    Hirata, Tsuyoshi
    Hakozaki, Taiki
    JOURNAL OF THORACIC DISEASE, 2023, 15 (07) : 3554 - 3556
  • [6] Efficacy and safety of second-line chemotherapy for patients with advanced non-small cell lung cancer complicated by interstitial lung disease
    Otsuka, Kenji
    Nokihara, Hiroshi
    Mitsuhashi, Atsushi
    Ozaki, Ryohiko
    Yabuki, Yohei
    Yoneda, Hiroto
    Ogino, Hirokazu
    Nishioka, Yasuhiko
    THORACIC CANCER, 2022, 13 (21) : 2978 - 2984
  • [7] Weekly docetaxel as second-line chemotherapy in advanced non-small cell lung cancer: Phase II trial
    Serke, M
    Schoenfeld, N
    Loddenkemper, R
    ANTICANCER RESEARCH, 2004, 24 (2C) : 1211 - 1216
  • [8] Efficacy of First-line Chemotherapy Affects the Second-Line Setting Response in Patients with Advanced Non-Small Cell Lung Cancer
    Cao, Wa
    Li, Ai-Wu
    Ren, Sheng-Xiang
    Chen, Xiao-Xia
    Li, Wei
    Gao, Guang-Hui
    He, Ya-Yi
    Zhou, Cai-Cun
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (16) : 6799 - 6804
  • [9] Second-line treatment for advanced non-small cell lung cancer:: A systematic review
    Barlési, F
    Jacot, W
    Astoul, P
    Pujol, JL
    LUNG CANCER, 2006, 51 (02) : 159 - 172
  • [10] Efficacy and Safety of Nab-Paclitaxel as Second-line Chemotherapy for Locally Advanced and Metastatic Non-small Cell Lung Cancer
    Wong, Wenjing
    Sun, Ping
    Mu, Zhengbin
    Liu, Jiannan
    Yu, Caiyan
    Liu, Aina
    ANTICANCER RESEARCH, 2017, 37 (08) : 4687 - 4691
12345